The FDA has granted approval for a groundbreaking cell-based gene therapy aimed at treating recessive dystrophic epidermolysis bullosa (RDEB), a…
Browsing: FDAApproval
The FDA has approved Dupixent for the treatment of chronic spontaneous urticaria (CSU) in adults and children aged 12 and…
A new treatment has been approved by the FDA for adults suffering from a serious kidney disorder known as primary…
The U.S. Food and Drug Administration (FDA) has approved a groundbreaking new drug for the preventive treatment of hemophilia. This…
The U.S. Food and Drug Administration (FDA) has taken a significant step forward in pediatric neurology by approving the first…
The approval of the first treatment for pediatric Myasthenia Gravis marks a groundbreaking achievement in the medical field. This rare…
The approval of the first-ever treatment for pediatric myasthenia gravis marks a significant breakthrough in the field of neurology and…
The FDA has approved a groundbreaking gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that leads…
The FDA has approved a new nasal spray, Neffy, for the treatment of severe allergic reactions in children ages 4…
The FDA has approved a groundbreaking new treatment for stroke, marking the first new clot-busting drug to be introduced in…